Mark Cuban Cost Plus Drug Co. has seen exponential growth since its launch, supplying thousands of healthcare facilities with discounted generics in shortage.

The study analyzed EHRs from U.S. Department of Veterans Affairs patients between 2011 and 2019. Researchers reviewed data from 2,100 physicians at 105 EDs, covering over 2.1 million visits for ...

Healthcare executives are preparing for 2025, a year likely filled with profound challenges and big opportunities. From workforce shortages to financial pressures, technological advances, and policy ...

Lukas Voss hosts Adam Tanner from NRC Health to discuss evolving healthcare employee experience strategies. Topics include shifting from annual surveys to real-time feedback, empowering managers ...

The Joint Commission has revised its accreditation criteria for assisted living communities and nursing care centers with the aim of preventing workplace violence. The revisions will go into effect ...

Congress passes funding bill to prevent shutdown, but fails to avert 2.83% Medicare pay cut for physicians. AMA and MGMA urge retroactive action and permanent ...

UChicago Medicine AdventHealth GlenOaks hospital in Glendale Heights, Ill., has named Zachary Dye CFO. Mr. Dye has played key roles in major facility openings and expansions within Altamonte Springs, ...

For Ms. Walker, timeline and budget were the most critical metrics in managing the project. She introduced the "light"-based methodology to the construction team, a strategy she has used throughout ...

Middletown, N.Y.-based Garnet Health has promoted Dr. Aamir Gilani to associate chief medical officer of its medical group, Garnet Health Doctors.

AdventHealth's East Florida Division transitions to regional structure with new leaders for two regions, effective Jan. 12. Learn more in this news release.

Learn about the retirement of Avera Sacred Heart Hospital's CEO, Doug Ekeren, after 39 years in healthcare. Discover his leadership style and plans for the fut ...

Medline Industries confidentially files for IPO with U.S. Securities and Exchange Commission, potential valuation of $50 billion. Learn about Medline's history.